Amstutz, Ursula; Largiadèr, Carlo Rodolfo (2018). Genotype-guided fluoropyrimidine dosing: ready for implementation. The lancet oncology, 19(11), pp. 1421-1422. Elsevier 10.1016/S1470-2045(18)30744-7
![[img]](https://boris.unibe.ch/style/images/fileicons/text.png) |
Text
1-s2.0-S1470204518307447-main.pdf - Published Version Restricted to registered users only Available under License Publisher holds Copyright. Download (136kB) | Request a copy |
Item Type: |
Journal Article (Further Contribution) |
|---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Amstutz, Ursula, Largiadèr, Carlo Rodolfo |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
1474-5488 |
Publisher: |
Elsevier |
Language: |
English |
Submitter: |
Marie-Christine Müller |
Date Deposited: |
06 Feb 2019 14:43 |
Last Modified: |
05 Dec 2022 15:26 |
Publisher DOI: |
10.1016/S1470-2045(18)30744-7 |
PubMed ID: |
30348539 |
BORIS DOI: |
10.7892/boris.125807 |
URI: |
https://boris.unibe.ch/id/eprint/125807 |
Actions (login required)
 |
Edit item |